According to Krishan, the stock is a 'buy' at the current level, with a target price of Rs 640 and a stop loss of Rs 595. It ...
Glenmark Pharmaceuticals, an India-based drug manufacturer has issued a voluntary recall affecting nearly 1.48 million bottles of atomoxetine, a generic medication used to treat ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback